125 related articles for article (PubMed ID: 26475981)
1. Statins and hip fracture risk in men: a population-based case-control study.
Adams AL; Shi JM; Reynolds K; Haque R; Cheetham TC; Kawatkar AA; Fithian DC; Jacobsen SJ
Ann Epidemiol; 2015 Nov; 25(11):844-8. PubMed ID: 26475981
[TBL] [Abstract][Full Text] [Related]
2. Hip fracture risk in statin users--a population-based Danish case-control study.
Rejnmark L; Olsen ML; Johnsen SP; Vestergaard P; Sørensen HT; Mosekilde L
Osteoporos Int; 2004 Jun; 15(6):452-8. PubMed ID: 15205716
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women.
Chan KA; Andrade SE; Boles M; Buist DS; Chase GA; Donahue JG; Goodman MJ; Gurwitz JH; LaCroix AZ; Platt R
Lancet; 2000 Jun; 355(9222):2185-8. PubMed ID: 10881890
[TBL] [Abstract][Full Text] [Related]
4. Proton-pump inhibitor use and hip fractures in men: a population-based case-control study.
Adams AL; Black MH; Zhang JL; Shi JM; Jacobsen SJ
Ann Epidemiol; 2014 Apr; 24(4):286-90. PubMed ID: 24507954
[TBL] [Abstract][Full Text] [Related]
5. Statin use and hip fractures in U.S. kidney transplant recipients.
Vangala C; Lenihan CR; Montez-Rath ME; Nair SS; Navaneethan SD; Ramanathan V; Winkelmayer WC
BMC Nephrol; 2017 May; 18(1):145. PubMed ID: 28460645
[TBL] [Abstract][Full Text] [Related]
6. HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients.
Wang PS; Solomon DH; Mogun H; Avorn J
JAMA; 2000 Jun; 283(24):3211-6. PubMed ID: 10866868
[TBL] [Abstract][Full Text] [Related]
7. Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study.
Rejnmark L; Vestergaard P; Mosekilde L
Calcif Tissue Int; 2006 Jul; 79(1):27-36. PubMed ID: 16868664
[TBL] [Abstract][Full Text] [Related]
8. Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials.
Bauer DC; Mundy GR; Jamal SA; Black DM; Cauley JA; Ensrud KE; van der Klift M; Pols HA
Arch Intern Med; 2004 Jan; 164(2):146-52. PubMed ID: 14744837
[TBL] [Abstract][Full Text] [Related]
9. Association between 5-alpha reductase inhibition and risk of hip fracture.
Jacobsen SJ; Cheetham TC; Haque R; Shi JM; Loo RK
JAMA; 2008 Oct; 300(14):1660-4. PubMed ID: 18840839
[TBL] [Abstract][Full Text] [Related]
10. Statin use and risk of prostate cancer: a Danish population-based case-control study, 1997-2010.
Jespersen CG; Nørgaard M; Friis S; Skriver C; Borre M
Cancer Epidemiol; 2014 Feb; 38(1):42-7. PubMed ID: 24275259
[TBL] [Abstract][Full Text] [Related]
11. Adherence to statin therapy and the incidence of ischemic stroke in patients with diabetes.
Korhonen MJ; Ruokoniemi P; Ilomäki J; Meretoja A; Helin-Salmivaara A; Huupponen R
Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):161-9. PubMed ID: 26687512
[TBL] [Abstract][Full Text] [Related]
12. Case-control study examining the association between hip fracture risk and statins therapy in old people.
Cheng KC; Liao KF; Lin CL; Lin CC; Lai SW
Medicine (Baltimore); 2019 Oct; 98(41):e17476. PubMed ID: 31593109
[TBL] [Abstract][Full Text] [Related]
13. Statin use and the risk of esophageal cancer: a population-based case-control study.
Chan TF; Chiu HF; Wu CH; Lin CL; Yang CY
Expert Opin Drug Saf; 2013 May; 12(3):293-8. PubMed ID: 23470154
[TBL] [Abstract][Full Text] [Related]
14. Use of statins and the risk of acute pancreatitis: a population-based case-control study.
Kuoppala J; Pulkkinen J; Kastarinen H; Kiviniemi V; Jyrkkä J; Enlund H; Happonen P; Paajanen H
Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1085-92. PubMed ID: 26300102
[TBL] [Abstract][Full Text] [Related]
15. HMG-CoA reductase inhibitors and the risk of vertebral fracture.
Schoofs MW; Sturkenboom MC; van der Klift M; Hofman A; Pols HA; Stricker BH
J Bone Miner Res; 2004 Sep; 19(9):1525-30. PubMed ID: 15312254
[TBL] [Abstract][Full Text] [Related]
16. Statins and hip fracture prevention--a population based cohort study in women.
Helin-Salmivaara A; Korhonen MJ; Lehenkari P; Junnila SY; Neuvonen PJ; Ruokoniemi P; Huupponen R
PLoS One; 2012; 7(10):e48095. PubMed ID: 23144731
[TBL] [Abstract][Full Text] [Related]
17. Use of Statins and Hip Fracture Risk: a Case-Control Study.
Del Chiaro A; Marchetti S; Parchi PD; Caprili G; Ipponi E; Scaglione M
Acta Chir Orthop Traumatol Cech; 2022; 89(2):104-107. PubMed ID: 35621399
[TBL] [Abstract][Full Text] [Related]
18. Patterns of medication adherence in a multi-ethnic cohort of prevalent statin users diagnosed with breast, prostate, or colorectal cancer.
Banegas MP; Emerson MA; Adams AS; Achacoso NS; Chawla N; Alexeeff S; Habel LA
J Cancer Surviv; 2018 Dec; 12(6):794-802. PubMed ID: 30338462
[TBL] [Abstract][Full Text] [Related]
19. Statin use and the risk of bladder cancer: a population-based case-control study.
Kuo CC; Chiu HF; Lee IM; Kuo HW; Lee CT; Yang CY
Expert Opin Drug Saf; 2012 Sep; 11(5):733-8. PubMed ID: 22849562
[TBL] [Abstract][Full Text] [Related]
20. Statin use and risk of first-time psoriasis diagnosis.
Brauchli YB; Jick SS; Meier CR
J Am Acad Dermatol; 2011 Jul; 65(1):77-83. PubMed ID: 21529997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
